• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform

    Diagnostic Desperation: A Look at IVD Trends During COVID-19

    Resourceful Resources: Materials Make a Difference During the Pandemic

    Stressed Testing: Challenges with Medical Device Testing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Cretex CFO Announces Retirement

    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning

    First Reported Use of Pulse Biosciences' CellFX System

    EUA Granted for New COVID-19, Flu A, Flu B Combo Kit

    EchoNous Expands Its Kosmos Hardware Platform
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform

    Diagnostic Desperation: A Look at IVD Trends During COVID-19

    Resourceful Resources: Materials Make a Difference During the Pandemic

    Stressed Testing: Challenges with Medical Device Testing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cybersecurity Compromises, Courtesy of COVID-19

    A Look at the Actual Device Costs for Hospitals

    Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

    FDA Making Progress With Technology and Data Action Plans

    What’s Hot Now in Medtech M&A
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    maxon

    Creganna Medical, part of TE Connectivity

    Unicep

    Concise Engineering

    Spectrum Plastics Group
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Grant Funding Works and How It Can Help

    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Qosina Corp.

    Spectrum Plastics Group

    Concise Engineering

    PTI Engineered Plastics Inc.

    FUTEK Advanced Sensor Technology Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    First Come, First Served: Class I Manufacturers Stand in Line for EU MDR Certification

    The days remaining to attain EU Medical Device Regulation (MDR) compliance are numbered.

    First Come, First Served:  Class I Manufacturers Stand in Line for EU MDR Certification
    Peter Rose, Managing Director—Europe, Maetrics09.06.19
    The days remaining to attain EU Medical Device Regulation (MDR) compliance are numbered, while the notified bodies central to manufacturers achieving said compliance are few and far between. With a significant shortage of notified bodies in the European regulatory arena, the risk is real for manufacturers who wait too long to get their compliance matters in order. Any manufacturer unable to receive CE certification by the upcoming deadline on May 26, 2020, or by the end of any extended transition period according to current Medical Device Directive (MDD) certificate expiry date, will have to deal with the regrettable consequence of having their products removed from the EU market, and any associated cash-flow repercussions and reputational damages to their business.

    Particularly vulnerable to being left behind are Class I manufacturers who cannot benefit from any extended transition period, some of whom may not even be aware of their entanglement with the new regulation’s requirements, given their exemption from such obligations under the previous directive. EU MDR compliance does not solely apply to manufacturers of high-risk products as it is commonly assumed but to all manufacturers regardless of past classification, including Class I. With such misconceptions floating around, it is important to set things straight for all manufacturers. This article will aim to clarify matters, highlighting the principle changes and challenges that moving away from the previous MDD and embarking on the road toward EU MDR compliance entails, with a particular focus on the urgency for manufacturers to promptly join the queue for notified body assistance now, as they are likely to have to wait their turn for a full review of all technical documentation.

    As a first point of action, manufacturers are advised to consult Annex VIII of the EU MDR, which will reveal any changes of classification, and in turn, any potential new conformity assessment routes they are to follow for their products. Indeed, the EU MDR contains not only four new classification rules but also some significant changes to pre-existing ones, some of which will altogether alter the category under which a product falls. Manufacturers must therefore swiftly become acquainted with these modifications, in order to first determine if their products have been up-classified to another sub-section of Class I, Class IIa, IIb, and Class III, or alternatively, if their product grouping remains untouched. If a manufacturer’s device remains a Class I device under the EU MDR, they may continue to self-certify as long as their technical documentation is up to date in time for the MDR deadline, for which they will need to self-declare the conformity of their devices with the requirements of the MDR and register relevant details on the EUDAMED database.

    For Class I manufacturers that have found their products to be up-classified, however, this reshuffling may result in their devices being subject to regulation by a notified body for the first time. One particular illustration of this is Class I reusable surgical instruments, which as per Article 52 (7c) of the EU MDR, will now belong to a new category of their own, known as Class Ir. Products that fall under the new Class Ir group will require inspection of cleaning, repackaging, and reprocessing aspects from a notified body—something unprecedented given no such reviews were required for these products under the MDD. Other examples of this restructuring include spinal products (MDR Annex VII, rule 8), standalone software (MDR Annex VII, rule 11), and products without an intended medical purpose (Annex XVI). Similarly, given that grandfathering of products is not allowed under the EU MDR, medical devices that have already been circulating on the market for many years, but entered the market prior to an ongoing standard, directive, or regulation, will also need to receive new CE certification.

    Having established the classification of their products under the new regulation, manufacturers are ready to begin taking the first steps toward achieving EU MDR compliance. This stage of the process will be most effective if manufacturers are able to establish a timeline for the implementation of these next stages of the operation. While some medical device manufacturers may have already initiated implementation efforts, others will require more time and guidance. Each business must therefore try to assess the timeframe and resources required to bring their compliance plans to fruition. The need for speed and efficiency is particularly crucial for Class I manufacturers; while other Classes of manufacturers who have been recertified under the MDD before 2020 can benefit from up to a four-year extension for the completion of compliance, Class I manufacturers have not been granted any additional time allowance and must achieve compliance by May 26, 2020.

    Adding to the urgency of the situation is the untimely shortage of notified bodies operating throughout Europe, with multiple organizations withdrawing from medical device regulation, and the resulting issue of capacity across the medical device industry. With only three notified bodies having presently been designated under the EU MDR (the announcement of Germany-based Dekra Certification GmbH came in August), the regulatory expertise vital in assisting manufacturers will be hard to come by. It is estimated the number of available notified bodies will significantly rise before the end of 2019, suggesting the work would be divided up between approximately 16 to 20 notified bodies. While this is an improvement, the vast number of technical documents being submitted for review means these organizations will nonetheless undoubtedly find themselves overstretched. It is evident the number of cases waiting for a CE mark will largely outweigh the combined capacity of the available notified bodies and lead to delays. With a clear surplus of demand for regulatory certification services on the horizon, manufacturers must act quickly. If Class I manufacturers find their products have been up-classified, they should engage with a notified body right away before the latter find themselves at full capacity. Class I manufacturers too slow to join the regulatory waiting room may find their technical documentation has not been reviewed in time and may simply be left behind from the collective migration from MDD to EU MDR.

    Needless to say, notified bodies are unlikely to have any time to offer any additional support, given the already strenuous task of delivering the bare minimum of essential reviews on time. Hard pressed to find the kind of supplementary support manufacturers may wish for, it is probable some manufacturers may wisely seek out regulatory expertise elsewhere. This kind of auxiliary assistance would be particularly beneficial for Class I manufacturers that have never been required to previously seek notified body review. By engaging with other expert entities, manufacturers will be able to gain immediate access to regulatory assistance while waiting in line for a notified body. This will not only diminish the huge strain on these organizations, but also allow manufacturers to ensure their technical documentation is all in order before submission, thus enabling an efficient, hassle-free compliance process for themselves. Moreover, in light of the uncertainty around Brexit, manufacturers are strongly encouraged to engage an Authorized Representative within the EU 27 in order to prepare as best as possible for the upcoming deadline and any eventual complications or delays.

    At the forefront of a successful transition is the gathering of clinical data. Most Class I manufacturers are currently self-certified and rarely have the necessary quality management system or the clinical data to reach EU MDR compliance alone. Additional support would certainly be helpful in completing the new Quality Management System (QMS) requirements demanded of manufacturers under the EU MDR. Class I manufacturers will now require a formal QMS as per Article 10, paragraph 9, of the regulation, which is best served by implementing EN ISO 13485:2016. The QMS must include requirements for a formal Post-Market Surveillance report, which must be continuously and proactively updated with relevant clinical data, as cited in Article 85. All manufacturers will be subject to the post-market provisions of the MDR, including Post-Market Clinical Follow-Up, Post-Market Surveillance Update Reports, and vigilance reporting. These new regulatory requisites represent a considerable reform from the basic procedures required under the MDD.

    By complying now, manufacturers can use available post-market clinical data or perform a post-market study to submit as clinical evidence within the technical documentation itself. On the other hand, manufacturers who fail to fulfill these specifications within the set deadlines will not only have to remove their non-compliant products from the EU market, but to make matters worse, will also be unable to collect precisely the clinical evidence needed to complete the technical documentation required for compliance. Such a scenario would be highly undesirable and problematic for any business. As such, Class I manufacturers should not underestimate the time, preparatory work, and resources required to meet total EU MDR compliance within the set times, and should engage with a notified body as soon as possible (if required), while also considering other available options of independent regulatory expertise. Complacency and insufficient resource and time allowances could prove highly damaging for ill-prepared manufacturers.

    Class I manufacturers who wait too long to get in line to review their technical documentation are placing themselves in a precarious situation. As a matter of urgency, manufacturers should first read EU MDR Annex VIII in order to determine which classificatory amendments may impact the compliance requirements of their products. Next, manufacturers must immediately reach out to a notified body to achieve CE marking before waiting lines become too long and advisory capabilities are completely depleted. Finally, manufacturers are urged to seek out some supplementary expertise, to help ease the weight placed on the shoulders of notified bodies and to guarantee a smooth transition procedure for all. To successfully receive their required CE certifications by May 26, 2020, Class I manufacturers must prioritize EU MDR conformity and allow for enough time to gather the obligatory clinical data and have these reviewed by a notified body. With this deadline rapidly approaching, it is essential manufacturers recognize the overdemand for notified body input and quickly start piecing together their EU MDR technical documentation to submit for a speedy review. 


    Peter Rose is the managing director and practice leader for Maetrics’ operations in Europe. Having worked in the medical device industry for over 20 years, Rose has a wealth of experience and knowledge in quality systems and regulatory affairs. He is a lead auditor and a qualified microbiologist, and has been recognized for his extensive experience with sterilization. 
    Related Searches
    • cleaning
    • medical
    • iso
    • iso 13485

    Related Columns

    • Software & IT
      Cybersecurity Compromises, Courtesy of COVID-19

      Cybersecurity Compromises, Courtesy of COVID-19

      As the healthcare industry focused its energies last year on battling SARS-CoV-2, cybercriminals used the distraction to their advantage.
      Michael Barbella, Managing Editor 03.04.21

    • A Look at the Actual Device Costs for Hospitals

      A Look at the Actual Device Costs for Hospitals

      According to a 2018 clinical journal article, U.S. hospitals spent approximately $200 billion on medical devices.
      Maria Shepherd, President and Founder, Medi-Vantage 03.04.21

    • Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

      Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

      For small businesses, trade shows are a critical part of developing new business as well as maintaining contacts.
      Dawn A. Lissy, Founder & President, Empirical 03.04.21


    • FDA Making Progress With Technology and Data Action Plans

      FDA Making Progress With Technology and Data Action Plans

      There is an urgent need to get advanced technologies into the healthcare ecosystem, but all products must first get regulatory approval.
      Alan Rencher, Vice President, Engineering, MasterControl 03.04.21

    • What’s Hot Now in Medtech M&A

      What’s Hot Now in Medtech M&A

      Every M&A cycle in the life sciences/medtech sector fosters exciting deals that interestingly impact the industry in both the short and long term.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 03.04.21

    • Software & IT
      Three Ways to Fast-Track the Total Product Lifecycle

      Three Ways to Fast-Track the Total Product Lifecycle

      Here are three ways leaders including Alcon, Baxter Healthcare, Boston Scientific, Epredia, and Illumina are driving innovation in medtech.
      Seth Goldenberg, Ph.D., Vice President, MedTech, Veeva Systems 03.04.21


    • Materials
      Role and Benefits of Plastics in the COVID-19 Vaccine Rollout

      Role and Benefits of Plastics in the COVID-19 Vaccine Rollout

      With some estimating the U.S. needs at least 850 million syringes for every person to receive the vaccine—plastics will play a significant role.
      Josh Blackmore, Global Healthcare Manager, M. Holland Company 03.03.21

    • R&D & Design
      Six Questions to Consider in Developing a Home Healthcare Device

      Six Questions to Consider in Developing a Home Healthcare Device

      These design decisions stem from questions relative to in-home use and 60601-1-11 compliance.
      Rachael Scott, Lead Electrical Engineer, Key Tech 03.03.21

    • Digital Health
      Five Themes to Watch as Digital Health Takes Center Stage

      Five Themes to Watch as Digital Health Takes Center Stage

      Here are five themes to watch in the sector, including what life sciences developers and investors should know about the current deal-making landscape.
      Stephen W. Bernstein, Partner, McDermott Will & Emery 03.03.21


    • Surgical
      Rethink Your Medtech ASC Strategy, Part 1

      Rethink Your Medtech ASC Strategy, Part 1

      ASCs have adopted a strategy to focus on predictable, low-risk procedures with lower complication rates in an out-of-hospital setting.
      Maria Shepherd, President and Founder, Medi-Vantage 02.03.21

    • R&D & Design
      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic restrictions may have diminished certain advantages large companies hold over small and mid-sized competitors.
      Dawn A. Lissy, President & Founder, Empirical 02.03.21

    • Tips for Reigniting Your MDR/IVDR Preparation

      Tips for Reigniting Your MDR/IVDR Preparation

      To get the MDR/IVDR preparation ball rolling again, here are four processes to help refocus on achieving compliance with the updated regulations.
      Nicolle Cannon, Founder and CEO, Cannon Quality Group LLC 02.03.21


    • Materials
      Three Major Innovation Opportunities for Biomedical Textiles

      Three Major Innovation Opportunities for Biomedical Textiles

      Biomedical textiles are gaining significant momentum for use in medical devices to facilitate less invasive surgical procedures.
      John Greco, Vice President of Sales, Cortland Biomedical 02.03.21

    • Contract Manufacturing
      Use Vertical Integration to Increase Productivity, Drive Innovation

      Use Vertical Integration to Increase Productivity, Drive Innovation

      The concept of vertical integration is simple: a company combining two or more stages of production that would normally be operated by separate companies.
      Ryan Lipe, Senior Vice President of Sales & Marketing, MGS 02.03.21

    • How to Better Prepare for Regulatory Requests and Minimize Impact

      How to Better Prepare for Regulatory Requests and Minimize Impact

      Pressure to increase efficiency in medical device development has been prevalent over the past year, especially with the intensified regulatory expectations.
      Sandi Schaible, Sherry Parker and Kim Ehman, WuXi AppTec Medical Device Testing 02.03.21


    Trending
    • Plastikos Medical Begins Phase II Of Expansion
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • FDA Clears ENvizion's Personalized Feeding Tube Placement Device
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Cheetah Medical Introduces Noninvasive Monitoring System
    Breaking News
    • Cretex CFO Announces Retirement
    • New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    • First Reported Use of Pulse Biosciences' CellFX System
    • EUA Granted for New COVID-19, Flu A, Flu B Combo Kit
    • EchoNous Expands Its Kosmos Hardware Platform
    View Breaking News >
    CURRENT ISSUE

    March 2021

    • Stressed Testing: Challenges with Medical Device Testing
    • Resourceful Resources: Materials Make a Difference During the Pandemic
    • Diagnostic Desperation: A Look at IVD Trends During COVID-19
    • Digitize Your QMS via an Enterprise Cloud Platform
    • Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Thymoquinone Inhibits Viral Infection in In Vitro Settings, New Study Finds
    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Coatings World

    Latest Breaking News From Coatings World

    Sherwin-Williams Announces Resignation of President, COO
    Ashland Completes Expansion, Relocation of Viatel Bioresorbable Polymers Manufacturing Facility
    Evonik Receives Sustainability Award from EcoVadis
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex CFO Announces Retirement
    New AI-Based Tool Developed for Coronary Artery Analysis, Intervention Planning
    First Reported Use of Pulse Biosciences' CellFX System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AGC Biologics Expands Cell and Gene Facility in Italy
    Celonic to Boost Cell & Gene Therapy Production
    Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Ulta Beauty Opens in Herald Square
    Elizabeth Arden Taps Sui He as Global Brand Ambassador
    Natura &Co Outperforms the Global Market in Q4 2020
    Happi

    Latest Breaking News From Happi

    What You're Reading on Happi.com
    Indie Beauty Innovators Wanted
    Cosmetic Chemists Seek Mentors
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Arjobex America welcomes Maggie Naberezny to sales team
    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Colfax Decides to Divide Its Businesses
    Stryker Corp.'s 2020 Sales Slip 3.6 Percent
    Bioventus Appoints Managing Director, China and Asia Pacific
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login